Press Releases
Quaker Houghton Announces Second Quarter 2022 Results
- Record net sales of
$492.4 million increased 13% compared to Q2'21 driven by higher selling prices - Reported net income of
$14.3 million and earnings per diluted share of$0.80 - Delivered
$58.5 million of adjusted EBITDA and$1.32 of non-GAAP earnings per diluted share - Successfully amended our credit agreement and extended our maturity profile to
June 2027
Three Months Ended |
Six Months Ended |
||||||||||
($ in millions, except per share data) |
2022 |
2021 |
2022 |
2021 |
|||||||
Net sales |
$ 492.4 |
$ 435.3 |
$ 966.6 |
$ 865.0 |
|||||||
Net income attributable to |
14.3 |
33.6 |
34.2 |
72.2 |
|||||||
Earnings per diluted share attributable to |
0.80 |
1.88 |
1.91 |
4.03 |
|||||||
Non-GAAP net income * |
23.7 |
32.4 |
49.1 |
70.4 |
|||||||
Non-GAAP earnings per diluted share * |
1.32 |
1.82 |
2.74 |
3.93 |
|||||||
Adjusted EBITDA * |
58.5 |
70.1 |
118.9 |
147.2 |
|||||||
* Refer to the Non-GAAP Measures and Reconciliations section below for additional information |
Second Quarter 2022 Consolidated Results
Second quarter 2022 net sales were a record of
The Company generated net income in the second quarter of 2022 of
Looking ahead, our focus remains on executing on items within our control. We are actively working with our customers to get the needed pricing to offset the persistent inflationary pressures on our margins while remaining vigilant on our costs. Therefore, despite significant uncertainty caused by several macroeconomic factors, we continue to expect to deliver sequential gross margin expansion and earnings growth in the second half of 2022."
Second Quarter 2022 Segment Results
The Company's second quarter 2022 operating performance of each of its four reportable operating segments: (i)
Three Months Ended |
Six Months Ended |
||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||
|
$ 172.7 |
$ 139.7 |
$ 326.9 |
$ 274.5 |
|||||
EMEA |
123.1 |
123.4 |
248.7 |
243.3 |
|||||
|
99.8 |
91.6 |
204.1 |
188.3 |
|||||
Global Specialty Businesses |
96.8 |
80.6 |
186.9 |
159.0 |
|||||
Segment operating earnings* |
|||||||||
|
$ 33.8 |
$ 33.6 |
$ 63.0 |
$ 65.9 |
|||||
EMEA |
13.3 |
23.4 |
30.0 |
48.6 |
|||||
|
22.2 |
23.2 |
44.1 |
50.7 |
|||||
Global Specialty Businesses |
27.8 |
24.2 |
52.9 |
48.4 |
|||||
* Refer to the Segment Measures and Reconciliations section below for additional information
All four segments benefitted from double-digit increases in selling price and product mix in the second quarter of 2022 compared to the prior year quarter. Organic sales volumes increased approximately 10% in Global Specialty Businesses compared to the prior year quarter, while the other segments declined due to the impacts on sales volumes mentioned above. The EMEA and
All four segments benefitted from increases in selling price and product mix compared to the first quarter of 2022, as we continued our strategic pricing initiatives. Organic sales volumes increased compared to the first quarter of 2022 in the Global Specialty Businesses and the
Cash Flow and Liquidity Highlights
The Company had a net operating cash outflow of
During the second quarter of 2022, the Company successfully amended its credit agreement and extended the maturity from
Non-GAAP Measures and Reconciliations
The information included in this press release includes non-GAAP (unaudited) financial information that includes EBITDA, adjusted EBITDA, adjusted EBITDA margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP net income and non-GAAP earnings per diluted share. The Company believes these non-GAAP financial measures provide meaningful supplemental information as they enhance a reader's understanding of the financial performance of the Company, are indicative of future operating performance of the Company, and facilitate a comparison among fiscal periods, as the non-GAAP financial measures exclude items that are not indicative of future operating performance or not considered core to the Company's operations. Non-GAAP results are presented for supplemental informational purposes only and should not be considered a substitute for the financial information presented in accordance with GAAP.
The Company presents EBITDA which is calculated as net income attributable to the Company before depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies. The Company also presents adjusted EBITDA which is calculated as EBITDA plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. In addition, the Company presents non-GAAP operating income which is calculated as operating income plus or minus certain items that are not indicative of future operating performance or not considered core to the Company's operations. Adjusted EBITDA margin and non-GAAP operating margin are calculated as the percentage of adjusted EBITDA and non-GAAP operating income to consolidated net sales, respectively. The Company believes these non-GAAP measures provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
Additionally, the Company presents non-GAAP net income and non-GAAP earnings per diluted share as additional performance measures. Non-GAAP net income is calculated as adjusted EBITDA, defined above, less depreciation and amortization, interest expense, net, and taxes on income before equity in net (loss) income of associated companies, in each case adjusted, as applicable, for any depreciation, amortization, interest or tax impacts resulting from the non-core items identified in the reconciliation of net income attributable to the Company to adjusted EBITDA. Non-GAAP earnings per diluted share is calculated as non-GAAP net income per diluted share as accounted for under the "two-class share method." The Company believes that non-GAAP net income and non-GAAP earnings per diluted share provide transparent and useful information and are widely used by investors, analysts, and peers in our industry as well as by management in assessing the operating performance of the Company on a consistent basis.
As it relates to 2022 projections for the Company as well as other forward-looking information described further above, the Company has not provided guidance for comparable GAAP measures or a quantitative reconciliation of forward-looking non-GAAP financial measures to the most directly comparable
The Company's reference to trailing twelve months adjusted EBITDA within this press release refers to the twelve month period ended
Certain of the prior period non-GAAP financial measures presented in the following tables have been adjusted to conform with current period presentation. The following tables reconcile the Company's non-GAAP financial measures (unaudited) to their most directly comparable GAAP (unaudited) financial measures (dollars in thousands unless otherwise noted, except per share amounts):
Non-GAAP Operating Income and Margin Reconciliations
Three Months Ended |
Six Months Ended |
||||||||||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||||||||||
Operating income |
$ 31,903 |
$ 38,816 |
$ 61,306 |
$ 83,710 |
|||||||||||||||||||
Combination, restructuring and other acquisition-related expenses (a) |
1,831 |
7,082 |
6,704 |
15,288 |
|||||||||||||||||||
Strategic planning and transformation expenses |
3,112 |
— |
6,200 |
— |
|||||||||||||||||||
Executive transition costs |
645 |
308 |
1,184 |
812 |
|||||||||||||||||||
|
929 |
— |
2,095 |
— |
|||||||||||||||||||
Other charges |
385 |
242 |
476 |
293 |
|||||||||||||||||||
Non-GAAP operating income |
$ 38,805 |
$ 46,448 |
$ 77,965 |
$ 100,103 |
|||||||||||||||||||
Non-GAAP operating margin (%) |
7.9 % |
10.7 % |
8.1 % |
11.6 % |
|||||||||||||||||||
EBITDA, Adjusted EBITDA, Adjusted EBITDA Margin and Non-GAAP Net Income Reconciliations |
|||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||||||||||
Net income attributable to |
$ 14,343 |
$ 33,570 |
$ 34,159 |
$ 72,185 |
|||||||||||||||||||
Depreciation and amortization (a)(b) |
20,856 |
22,344 |
41,583 |
44,792 |
|||||||||||||||||||
Interest expense, net |
6,494 |
5,618 |
11,839 |
11,088 |
|||||||||||||||||||
Taxes on income before equity in net (loss) income |
1,374 |
15,218 |
4,240 |
25,907 |
|||||||||||||||||||
of associated companies (c) |
|||||||||||||||||||||||
EBITDA |
$ 43,067 |
$ 76,750 |
$ 91,821 |
$ 153,972 |
|||||||||||||||||||
Equity loss (income) in a captive insurance company |
1,781 |
(883) |
2,025 |
(3,963) |
|||||||||||||||||||
Combination, restructuring and other |
2,248 |
6,956 |
9,100 |
9,359 |
|||||||||||||||||||
acquisition-related expenses (a) |
|||||||||||||||||||||||
Strategic planning and transformation expenses |
3,112 |
— |
6,200 |
— |
|||||||||||||||||||
Executive transition costs |
645 |
308 |
1,184 |
812 |
|||||||||||||||||||
|
929 |
— |
2,095 |
— |
|||||||||||||||||||
Brazilian non-income tax credits |
— |
(13,293) |
— |
(13,293) |
|||||||||||||||||||
Loss on extinguishment of debt |
6,763 |
— |
6,763 |
— |
|||||||||||||||||||
Other charges |
(54) |
219 |
(253) |
318 |
|||||||||||||||||||
Adjusted EBITDA |
$ 58,491 |
$ 70,057 |
$ 118,935 |
$ 147,205 |
|||||||||||||||||||
Adjusted EBITDA margin (%) |
11.9 % |
16.1 % |
12.3 % |
17.0 % |
|||||||||||||||||||
Adjusted EBITDA |
$ 58,491 |
$ 70,057 |
$ 118,935 |
$ 147,205 |
|||||||||||||||||||
Less: Depreciation and amortization - adjusted (a)(b) |
20,856 |
22,218 |
41,583 |
44,251 |
|||||||||||||||||||
Less: Interest expense, net |
6,494 |
5,618 |
11,839 |
11,088 |
|||||||||||||||||||
Less: Taxes on income before equity in net (loss) |
7,466 |
9,773 |
16,368 |
21,512 |
|||||||||||||||||||
income of associated companies – adjusted (c) |
|||||||||||||||||||||||
Non-GAAP net income |
$ 23,675 |
$ 32,448 |
$ 49,145 |
$ 70,354 |
|||||||||||||||||||
Non-GAAP Earnings per Diluted Share Reconciliations |
|||||||||||||||||||||||
Three Months Ended |
Six Months Ended |
||||||||||||||||||||||
2022 |
2021 |
2022 |
2021 |
||||||||||||||||||||
GAAP earnings per diluted share attributable to Quaker |
$ 0.80 |
$ 1.88 |
$ 1.91 |
$ 4.03 |
|||||||||||||||||||
Equity loss (income) in a captive insurance company per diluted share |
0.10 |
(0.05) |
0.11 |
(0.22) |
|||||||||||||||||||
Combination, restructuring and other acquisition-related expenses per diluted share (a) |
0.13 |
0.30 |
0.41 |
0.42 |
|||||||||||||||||||
Strategic planning and transformation expenses per diluted share |
0.13 |
— |
0.27 |
— |
|||||||||||||||||||
Executive transition costs per diluted share |
0.03 |
0.02 |
0.05 |
0.04 |
|||||||||||||||||||
|
0.04 |
— |
0.10 |
— |
|||||||||||||||||||
Brazilian non-income tax credits per diluted share |
— |
(0.44) |
— |
(0.44) |
|||||||||||||||||||
Loss on extinguishment of debt per diluted share |
0.29 |
— |
0.29 |
— |
|||||||||||||||||||
Other charges per diluted share |
(0.00) |
0.01 |
(0.01) |
0.02 |
|||||||||||||||||||
Impact of certain discrete tax items per diluted share |
(0.20) |
0.10 |
(0.39) |
0.08 |
|||||||||||||||||||
Non-GAAP earnings per diluted share |
$ 1.32 |
$ 1.82 |
$ 2.74 |
$ 3.93 |
(a) |
The Company recorded |
(b) |
Depreciation and amortization for the three and six months ended |
(c) |
Taxes on income before equity in net (loss) income of associated companies – adjusted includes the Company's tax expense adjusted for the impact of any current and deferred income tax expense (benefit), as applicable, of the reconciling items presented in the reconciliation of Net income attributable to |
Segment Measures and Reconciliations
The Company's operating segments, which are consistent with its reportable segments, reflect the structure of the Company's internal organization, the method by which the Company's resources are allocated and the manner by which the chief operating decision maker assesses the Company's performance. The Company has four reportable segments: (i)
The following tables reconcile the Company's reportable operating segments performance to that of the Company (dollars in thousands):
Three Months Ended |
Six Months Ended |
||||||||||
|
2022 |
2021 |
2022 |
2021 |
|||||||
|
$ 172,747 |
$ 139,673 |
$ 326,891 |
$ 274,544 |
|||||||
EMEA |
123,053 |
123,436 |
248,740 |
243,250 |
|||||||
|
99,828 |
91,559 |
204,062 |
188,265 |
|||||||
Global Specialty Businesses |
96,760 |
80,594 |
186,866 |
158,986 |
|||||||
Total net sales |
$ 492,388 |
$ 435,262 |
$ 966,559 |
$ 865,045 |
|||||||
Segment operating earnings |
|||||||||||
Americas |
$ 33,785 |
$ 33,648 |
$ 63,005 |
$ 65,882 |
|||||||
EMEA |
13,283 |
23,405 |
30,049 |
48,649 |
|||||||
Asia/Pacific |
22,226 |
23,227 |
44,133 |
50,705 |
|||||||
Global Specialty Businesses |
27,841 |
24,209 |
52,876 |
48,378 |
|||||||
Total segment operating earnings |
$ 97,135 |
$ 104,489 |
$ 190,063 |
$ 213,614 |
|||||||
Combination, integration and other acquisition-related expenses |
(1,832) |
(6,658) |
(5,885) |
(12,473) |
|||||||
Restructuring and related charges |
1 |
(298) |
(819) |
(1,473) |
|||||||
Fair value step up of acquired inventory sold |
— |
— |
— |
(801) |
|||||||
Non-operating and administrative expenses |
(48,579) |
(43,077) |
(92,042) |
(84,069) |
|||||||
Depreciation of corporate assets and amortization |
(14,822) |
(15,640) |
(30,011) |
(31,088) |
|||||||
Operating income |
31,903 |
38,816 |
61,306 |
83,710 |
|||||||
Other (expense) income, net |
(8,399) |
14,010 |
(10,605) |
18,697 |
|||||||
Interest expense, net |
(6,494) |
(5,618) |
(11,839) |
(11,088) |
|||||||
Income before taxes and equity in net (loss) income of |
$ 17,010 |
$ 47,208 |
$ 38,862 |
$ 91,319 |
Forward-Looking Statements
This press release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements can be identified by the fact that they do not relate strictly to historical or current facts. We have based these forward-looking statements, including statements regarding the potential effects of the COVID-19 pandemic, the
Conference Call
As previously announced, the Company's investor conference call to discuss its second quarter 2022 performance is scheduled for
About
|
|||||||
Condensed Consolidated Statements of Income |
|||||||
(Dollars in thousands, except per share data) |
|||||||
(Unaudited) |
|||||||
Three Months Ended |
Six Months Ended |
||||||
2022 |
2021 |
2022 |
2021 |
||||
Net sales |
$ 492,388 |
$ 435,262 |
$ 966,559 |
$ 865,045 |
|||
Cost of goods sold |
342,824 |
280,811 |
670,924 |
554,400 |
|||
Gross profit |
149,564 |
154,451 |
295,635 |
310,645 |
|||
% |
30.4 % |
35.5 % |
30.6 % |
35.9 % |
|||
Selling, general and administrative expenses |
115,830 |
108,679 |
227,625 |
212,989 |
|||
Restructuring and related (credits) charges, net |
(1) |
298 |
819 |
1,473 |
|||
Combination, integration and other acquisition-related expenses |
1,832 |
6,658 |
5,885 |
12,473 |
|||
Operating income |
31,903 |
38,816 |
61,306 |
83,710 |
|||
% |
6.5 % |
8.9 % |
6.3 % |
9.7 % |
|||
Other (expense) income, net |
(8,399) |
14,010 |
(10,605) |
18,697 |
|||
Interest expense, net |
(6,494) |
(5,618) |
(11,839) |
(11,088) |
|||
Income before taxes and equity in net (loss) income of associated companies |
17,010 |
47,208 |
38,862 |
91,319 |
|||
Taxes on income before equity in net (loss) income of associated companies |
1,374 |
15,218 |
4,240 |
25,907 |
|||
Income before equity in net (loss) income of associated companies |
15,636 |
31,990 |
34,622 |
65,412 |
|||
Equity in net (loss) income of associated companies |
(1,265) |
1,610 |
(430) |
6,820 |
|||
Net income |
14,371 |
33,600 |
34,192 |
72,232 |
|||
Less: Net income attributable to noncontrolling interest |
28 |
30 |
33 |
47 |
|||
Net income attributable to |
$ 14,343 |
$ 33,570 |
$ 34,159 |
$ 72,185 |
|||
% |
2.9 % |
7.7 % |
3.5 % |
8.3 % |
|||
Share and per share data: |
|||||||
Basic weighted average common shares outstanding |
17,834,329 |
17,802,366 |
17,830,218 |
17,793,915 |
|||
Diluted weighted average common shares outstanding |
17,841,377 |
17,849,521 |
17,847,404 |
17,846,010 |
|||
Net income attributable to |
$ 0.80 |
$ 1.88 |
$ 1.91 |
$ 4.04 |
|||
Net income attributable to |
$ 0.80 |
$ 1.88 |
$ 1.91 |
$ 4.03 |
|
|||
Condensed Consolidated Balance Sheets |
|||
(Dollars in thousands, except par value) |
|||
(Unaudited) |
|||
|
|
||
2022 |
2021 |
||
ASSETS |
|||
Current assets |
|||
Cash and cash equivalents |
$ 202,348 |
$ 165,176 |
|
Accounts receivable, net |
465,352 |
430,676 |
|
Inventories, net |
313,442 |
264,531 |
|
Prepaid expenses and other current assets |
64,674 |
59,871 |
|
Total current assets |
1,045,816 |
920,254 |
|
Property, plant and equipment, net |
192,497 |
197,520 |
|
Right of use lease assets |
36,317 |
36,635 |
|
Goodwill |
610,167 |
631,194 |
|
Other intangible assets, net |
962,580 |
1,027,782 |
|
Investments in associated companies |
83,678 |
95,278 |
|
Deferred tax assets |
10,897 |
16,138 |
|
Other non-current assets |
28,804 |
30,959 |
|
Total assets |
|
$ 2,955,760 |
|
LIABILITIES AND EQUITY |
|||
Current liabilities |
|||
Short-term borrowings and current portion of long-term debt |
$ 14,485 |
$ 56,935 |
|
Accounts and other payables |
253,782 |
234,083 |
|
Accrued compensation |
29,359 |
38,197 |
|
Accrued restructuring |
3,812 |
4,087 |
|
Other accrued liabilities |
99,287 |
97,165 |
|
Total current liabilities |
400,725 |
430,467 |
|
Long-term debt |
972,369 |
836,412 |
|
Long-term lease liabilities |
25,695 |
26,335 |
|
Deferred tax liabilities |
156,468 |
179,025 |
|
Other non-current liabilities |
84,933 |
95,599 |
|
Total liabilities |
1,640,190 |
1,567,838 |
|
Equity |
|||
Common stock, |
17,920 |
17,897 |
|
Capital in excess of par value |
921,642 |
917,053 |
|
Retained earnings |
535,621 |
516,334 |
|
Accumulated other comprehensive loss |
(145,246) |
(63,990) |
|
Total Quaker shareholders' equity |
1,329,937 |
1,387,294 |
|
Noncontrolling interest |
629 |
628 |
|
Total equity |
1,330,566 |
1,387,922 |
|
Total liabilities and equity |
|
$ 2,955,760 |
|
|||
Condensed Consolidated Statements of Cash Flows |
|||
(Dollars in thousands) |
|||
(Unaudited) |
|||
Six Months Ended |
|||
2022 |
2021 |
||
Cash flows from operating activities |
|||
Net income |
$ 34,192 |
$ 72,232 |
|
Adjustments to reconcile net income to net cash used in operating activities: |
|||
Amortization of debt issuance costs |
2,236 |
2,375 |
|
Depreciation and amortization |
41,036 |
44,188 |
|
Equity in undistributed earnings of associated companies, net of dividends |
3,400 |
(6,715) |
|
Acquisition-related fair value adjustments related to inventory |
- |
801 |
|
Deferred compensation, deferred taxes and other, net |
(10,223) |
(13,849) |
|
Share-based compensation |
5,433 |
6,134 |
|
Loss on extinguishment of debt |
5,246 |
- |
|
Loss (gain) on disposal of property, plant, equipment and other assets |
15 |
(5,356) |
|
Combination and other acquisition-related expenses, net of payments |
(3,880) |
(2,305) |
|
Restructuring and related charges |
819 |
1,473 |
|
Pension and other postretirement benefits |
(2,269) |
(2,223) |
|
(Decrease) increase in cash from changes in current assets and current liabilities, net of acquisitions: |
|||
Accounts receivable |
(51,944) |
(47,252) |
|
Inventories |
(58,427) |
(57,020) |
|
Prepaid expenses and other current assets |
(5,558) |
(20,111) |
|
Change in restructuring liabilities |
(797) |
(4,214) |
|
Accounts payable and accrued liabilities |
32,298 |
22,274 |
|
Net cash used in operating activities |
(8,423) |
(9,568) |
|
Cash flows from investing activities |
|||
Investments in property, plant and equipment |
(15,138) |
(6,974) |
|
Payments related to acquisitions, net of cash acquired |
(9,383) |
(29,424) |
|
Proceeds from disposition of assets |
85 |
14,744 |
|
Net cash used in investing activities |
(24,436) |
(21,654) |
|
Cash flows from financing activities |
|||
Payments of term loan debt |
(668,500) |
(19,065) |
|
Proceeds of term loan debt |
750,000 |
- |
|
Borrowings on revolving credit facilities, net |
16,703 |
29,433 |
|
Repayments on other debt, net |
(155) |
(219) |
|
Financing-related debt issuance costs |
(3,734) |
- |
|
Dividends paid |
(14,862) |
(14,113) |
|
Stock options exercised, other |
(821) |
(416) |
|
Net cash provided by (used in) financing activities |
78,631 |
(4,380) |
|
Effect of foreign exchange rate changes on cash |
(8,600) |
(683) |
|
Net increase (decrease) in cash, cash equivalents and restricted cash |
37,172 |
(36,285) |
|
Cash, cash equivalents and restricted cash at the beginning of the period |
165,176 |
181,895 |
|
Cash, cash equivalents and restricted cash at the end of the period |
|
|
View original content to download multimedia:https://www.prnewswire.com/news-releases/quaker-houghton-announces-second-quarter-2022-results-301600447.html
SOURCE
Jeffrey Schnell, Senior Director, Investor Relations, investor@quakerhoughton.com, T. 1.610.832.4087